A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT05633355 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
187
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen